Review
doi: 10.1080/21548331.1991.11705311.
Disease gene identification: ethical considerations
Affiliations
- PMID: 1833415
- DOI: 10.1080/21548331.1991.11705311
Item in Clipboard
Review
Disease gene identification: ethical considerations
Hosp Pract (Off Ed).
.
Abstract
How can we offer genetic testing and screening with adequate protection? Who will have access to the results? How do we balance a person's desire to know with the pain that knowledge may bring? We can examine these issues in the light of our experience with two fatal autosomal diseases: cystic fibrosis, in which the gene is known, and Huntington's disease, in which it is not.
Similar articles
-
Ethical issues in preclinical testing in Huntington disease: response to Margery Shaw's invited editorial comment.Am J Med Genet. 1987 Nov;28(3):761-3. doi: 10.1002/ajmg.1320280329. Am J Med Genet. 1987. PMID: 2962495 No abstract available.
-
Benefits and pitfalls of prenatal screening in a twin pregnancy.Int J Gynaecol Obstet. 2005 Nov;91(2):170-1. doi: 10.1016/j.ijgo.2005.07.015. Epub 2005 Sep 13. Int J Gynaecol Obstet. 2005. PMID: 16165136 No abstract available.
-
Presymptomatic testing for late-onset genetic disorders: lessons from Huntington's disease.FASEB J. 1992 Jul;6(10):2818-9. doi: 10.1096/fasebj.6.10.1386046. FASEB J. 1992. PMID: 1386046
-
Ethical considerations in choosing a model for population-based cystic fibrosis carrier screening.Med J Aust. 2010 Aug 2;193(3):157-60. doi: 10.5694/j.1326-5377.2010.tb03836.x. Med J Aust. 2010. PMID: 20678044 Review.
-
Issues related to DNA testing for Huntington's disease in symptomatic patients.Semin Neurol. 1997;17(3):235-8. doi: 10.1055/s-2008-1040934. Semin Neurol. 1997. PMID: 9311065 Review.
Cited by
-
Psychological features in persons at risk for familial Alzheimer's disease.Am J Alzheimers Dis Other Demen. 2001 May-Jun;16(3):157-62. doi: 10.1177/153331750101600311. Am J Alzheimers Dis Other Demen. 2001. PMID: 11398564 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical